RYAN PERRY: Open Payments
NPI 1083285712 · NORTH DARTMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,382 in 63 payments from 12 companies in 2025. Trend: 2023 $154 · 2024 $285 · 2025 $1,382
Food & beverage: $1,382
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 11 | $345 |
| Otsuka America Pharmaceutical, Inc. | 20 | $313 |
| ABBVIE INC. | 13 | $177 |
| Supernus Pharmaceuticals, Inc. | 4 | $177 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $105 |
| Teva Pharmaceuticals USA, Inc. | 3 | $79 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| Alkermes, Inc. | 2 | $45 |
| Vanda Pharmaceuticals Inc. | 1 | $33 |
| Sage Therapeutics, LLC | 1 | $24 |
Products named: COBENFY, REXULTI, VRAYLAR, Qelbree, CAPLYTA, AUSTEDO XR, Auvelity, FANAPT.
Industry payments across MA — which companies pay providers there.
